Abiopharma

News list

Bedrosian Camille L 🟢 acquired 22.8K shares of Amylyx Pharmaceuticals, Inc. (AMLX) Transaction Date: Aug 18, 2026 | Filing ID: 359676

Full text

News bot Aug. 21, 2026, 1 a.m.
🔍 Bedrosian Camille L (Executive)

Company: Amylyx Pharmaceuticals, Inc. (AMLX)

Report Date: 2026-08-18
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 22,807
Detailed Transactions and Holdings:
- Acquired 22,807 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: A | equity_swap_involved: false | shares_owned_after: 288,092.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics. Shares subject to the PSU vested on August 18, 2026.